Catherine Coste is Director of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 5,701 shares of BLFS, which is worth approximately $124,737. The most recent transaction as insider was on Mar 18, 2025, when has been sold 5,701 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.7K
n/a 3M change
n/a 12M change
Total Value Held $124,737

Catherine Coste Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2025
BUY
Grant, award, or other acquisition
-
5,701 Added 50.0%
5,701 Common Stock

Also insider at

RNLX
Renalytix plc Healthcare
UTRS
MINERVA SURGICAL INC Healthcare
BMRA
BIOMERICA INC Healthcare
CC

Catherine Coste

Director
Irvine, CA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS